Loading…
DIA Europe 2019 has ended
Wednesday, February 6 • 12:00 - 13:15
#S0402: Where Will Patients Come from in the Future? EHR and Biobanks

Sign up or log in to save this to your schedule and see who's attending!

Component Type: Session

There is no clinical research without patients who are willing to participate in clinical trials. As long as this paradigm is valid, finding the right patients is a key to success in clinical development. Sometimes one has to apply sophisticated concepts to find eligible patients, but more straightforward access strategies may be available with Biobanks and Electronic Health Records (EHRs). Representatives of both tools will discuss their value and limitations.

Chair

Peter Schueler, DrMed, MD

Speaker

Biobanks – What and Where They Are
Berthold Huppertz, PhD

“Anonymized Identification” Technology and its Use in EHR Clinical Trial Patient Search and Identification
Ian Rentsch, JD

How a Data-Driven Approach Can Lead Difficult to find Pediatrics Sickle Cell Disease Patients into Clinical Trials
Martim Goncalves, MBA

Roundtable: EHR - A Breakthrough in Patient Recruitment? - The View from National Competent Authority
Janet Valentine, PhD

Roundtable: EHR - A Breakthrough in Patient Recruitment? - The Obstacles
Peter Gocke

Roundtable: EHR - A Breakthrough in Patient Recruitment? - The Solutions
Christine Mueller, PhD



Speakers
PG

Peter Gocke

Chief Digital Officer, Charité Berlin
avatar for Martim Goncalves

Martim Goncalves

Global Solutions Manager (R&D), IQVIA
Martim Gonçalves is leading cross-functional projects for the Analytics Center of Excellence in a collaboratively way to find novel, differentiating solutions to challenging and complex problems. In this role, I am passionate about innovation, and new data science solutions at a... Read More →
avatar for Berthold Huppertz

Berthold Huppertz

Chair, Division of Cell Biology, Histology and Embryology, Medical University of Graz
Berthold Huppertz is PhD and professor of cell biology. From 2011 to 2017 he has been director and CEO of Biobank Graz, the largest clinical biobank in Europe with more than 20 million samples. During this time, Biobank Graz was awarded “Research Biobank of the Year” in 2014... Read More →
CM

Christine Mueller

Hospital Engagement Lead, Custodix NV
Christina Mueller holds a PhD in Biomedical Science from the University of Gent, Belgium as a continuation of her undergrad degree in Molecular Biology at the University of St. Andreas, Scotland. She has practical experiences in fundamental research for medication development, in... Read More →
avatar for Ian Rentsch

Ian Rentsch

Chief Executive Officer, Clinerion
Ian Rentsch has over 22 years’ experience in legal corporate affairs, outsourcing management working in large multinational companies including biopharmaceuticals, and more recently, general management experience leading regional clinical teams, CRO business operations and global... Read More →
avatar for Peter Schueler

Peter Schueler

Senior Vice President, Drug Development Neurosciences, ICON plc (CRO)
Peter Schüeler, MD, serves as Senior Vice President, Drug Development Neurosciences, for ICON plc (Germany). He joined ICON as Vice President for Medical Affairs and Drug Safety for Europe, and has authored an eBook about drug development methodology. Dr. Schüeler is Head Lecturer... Read More →
avatar for Janet Valentine

Janet Valentine

Director of Clinical Practice Research Datalink (CPRD), MHRA
Janet Valentine PhD joined the Clinical Practice Research Datalink (CPRD) as Director in 2015. CPRD is the UK Government real world health data research service supporting retrospective and prospective public health and clinical studies. Previously Janet was Head of Population Health... Read More →


Wednesday February 6, 2019 12:00 - 13:15
F1 Austria Center Vienna Bruno-Kreisky-Platz 1 1220 Vienna Austria
  • Featured Topics Clinical Development
  • Tags Session